Wednesday Nov 09, 2022

Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection

Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.

Read the full article:
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)

Continue this conversation on social!

Follow us today at...

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv

Comment (0)

No comments yet. Be the first to say something!

© 2026 The Lancet Group

Podcast Powered By Podbean

Version: 20241125